Although cognitive and functional decline are considered hallmarks of dementia, the vast majority of people living with dementia (PWD) also experience at least one neuropsychiatric symptom (NPS) in the course of the disease (1, 2) and NPS are especially prevalent in nursing home residents with dementia (3). Depression is among the most frequent NPS in dementia with reported prevalence rates ranging from 20 to 60% (4, 5). However, depression often goes undiagnosed and therefore untreated in PWD living in nursing homes (6–8), even though higher prevalence of depression has been reported for nursing home residents with dementia compared to residents without dementia (9, 10) and to community-dwelling PWD (11).
The relationship between dementia and depression is complex (12). Depressive symptoms occurring in later life are a known risk factor for the presence of cognitive deficits and dementia (13), however late onset of depressive symptoms can also constitute an early manifestation of dementia (14). In turn, dementia is a risk factor for depression due to psychological reaction to the cognitive and behavioral changes accompanying dementia (15). Comorbid depression in dementia is associated with a profound decrease in quality of life (16), accelerated cognitive decline (17) and increased mortality (18).
A number of suitable therapeutic options exist for treatment of depression in dementia (19, 20). However, accurate diagnosis of depression is essential in order to initiate appropriate interventions. It has been argued that numerous disease, clinician and system-level factors may hinder the diagnosis of depression in PWD (21, 22). Insufficient diagnosis of depression may also lead to inappropriate use of antidepressants, which has been reported in nursing home residents with and without dementia (23, 24). In this regard, Kramer et al. (25) found low concordance of depression diagnosis and prescriptions of antidepressants in PWD, similar findings have been reported by Kwak et al. (26). Moreover, Wetzels et al. (27) found a negative association of antidepressant medication with quality of life in PWD, a concept that is reportedly closely linked to depression (16).
While structured clinical interviews remain the goldstandard for diagnosis of depressive symptoms in dementia, self- and informant-rated assessments scales are usually applied for assessment of depressive symptoms in PWD under the real-world conditions of long-term care facilites (20). Although informant-ratings can be useful to objectify PWDs’ functional and cognitive status (28), they have been criticized for their paternalistic approach (29) and potential lack of validity for assessing more subjective outcomes such as well-being (30) and quality of life in PWD (31, 32). Regarding depressive symptoms, it remains unclear, whether and how information from these two modalities actually gives a consistent picture (33). Two studies compared self-ratings of depression using the Geriatrc Depression Scale (GDS) with informant-rating using the Neuropsychiatric Inventory (NPI) and found low agreement of both measures in community-dwelling people with mild dementia (26, 33). Similarly, other studies have reported low to moderate agreement between self- and informant-ratings of depression in community-dwelling PWD (34, 35) and PWD in nursing homes (36, 37). In contrast however, Arlt et al. (38) found good congruence of clinician and patient-rated depression in a cross-sectional study with mostly community-dwelling PWD.
Knowlegde is sparse about associations of self- and informant-depression ratings with other patient and context-related factors in nursing home residents with dementia. Gruber-Baldini et al. (39) investigated predictors of staff-rated depression in long-term care and found associations with disease-related factors, i.e., severe cognitive impairment, behavioral symptoms, and pain, as well as living in for-profit nursing homes. In a cross-sectional study with community-living PWD, Dawson et al. (40) found self-reported depression was predicted by physical strain and role captivity. To our knowlegde, factors associated with both self- and informant-ratings of depressive symptoms in nursing home residents with moderate to severe dementia have not been investigated in one and the same study. However, a systematic review including ten cross-sectional and three longitudinal studies on characteristics of self- and informant-ratings of quality of life of PWD in long-term care facilities revealed disparate association patterns within and across studies (16). For example, a population-based study demonstrated that self-ratings of quality of life are related to depression in PWD, whereas staff informant-ratings are more related to NPS and level of cognitive functioning (41). Similarly, a cross-sectional study by Beer et al. (32) also found that informant-ratings of quality of life are related to NPS, severe cognitive impairment and falls, whilst self-rated quality of life was related to physical restraint and pain. While there are hints about the differential association patterns between depressive symptoms and self- and informant-rated quality of life, the concordance of self- and informant-rated depressive symptom assessements in PWD and the specific association patterns with other constructs needs further investigation.
The present study
The aim of this cross-sectional study was (1) to determine the concordance between self- and informant-rated depressive symptoms in nursing home residents living with dementia (2) to investigate factors associated with both modalities and (3) to assess concordance of self- and informant-rated depressive symptoms with antidepressant medication. Based on previous findings, we expect only moderate concordance between self- and informant-rated depressive symptoms. We expect self-rated depression will be associated subjective factors such as functional abilty, meaning the capacity to carry out activities of daily living independently and self-reported quality of life, whilst informant-rated depressive symptoms will be associated with with caregiver and disease-related factors such as severity of NPS, dementia stage and informant-rated quality of life. Furthermore, low concordance of depressive symptoms with antidepressant medication is expected.